PubMed

Glycoprotein Ibalpha polymorphism T145M, elevated lipoprotein-associated phospholipase A2, and hypertriglyceridemia predict risk for recurrent coronary events in diabetic postinfarction patients.

Corsetti JP, Ryan D, Moss AJ, Rainwater DL, Zareba W, Sparks CE.

Diabetes. 2007 May;56(5):1429-35. Epub 2007 Feb 15.PMID: 17303802 [PubMed - indexed for MEDLINE]Related articlesFree article

High lipoprotein-associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarction patients.

Corsetti JP, Rainwater DL, Moss AJ, Zareba W, Sparks CE.

Clin Chem. 2006 Jul;52(7):1331-8. Epub 2006 May 18.PMID: 16709622 [PubMed - indexed for MEDLINE]Related articlesFree article

Lp(a) and risk of recurrent cardiac events in obese postinfarction patients.

Corsetti JP, Ryan D, Rainwater DL, Moss AJ, Zareba W, Block RC, Sparks CE.

Obesity (Silver Spring). 2008 Dec;16(12):2717-22. Epub 2008 Oct 16.PMID: 18927546 [PubMed - indexed for MEDLINE]Related articles

NAD(P)H oxidase polymorphism (C242T) and high HDL cholesterol associate with recurrent coronary events in postinfarction patients.

Corsetti JP, Ryan D, Moss AJ, Zareba W, Sparks CE.

Atherosclerosis. 2008 Jan;196(1):461-8. Epub 2007 Jan 9.PMID: 17214994 [PubMed - indexed for MEDLINE]Related articles

Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress.

Koenig W, Twardella D, Brenner H, Rothenbacher D.

Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1586-93. Epub 2006 Apr 20.PMID: 16627803 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients.

Corsetti JP, Ryan D, Moss AJ, Rainwater DL, Zareba W, Sparks CE.

Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):548-54. Epub 2007 Dec 20.PMID: 18096824 [PubMed - indexed for MEDLINE]Related articlesFree article

Platelet membrane glycoprotein Ibalpha gene -5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosis.

Douglas H, Michaelides K, Gorog DA, Durante-Mangoni E, Ahmed N, Davies GJ, Tuddenham EG.

Heart. 2002 Jan;87(1):70-4.PMID: 11751671 [PubMed - indexed for MEDLINE]Related articlesFree article

Role of Kozak sequence polymorphism of platelet glycoprotein Ibalpha as a risk factor for coronary artery disease and catheter interventions.

Meisel C, Afshar-Kharghan V, Cascorbi I, Laule M, Stangl V, Felix SB, Baumann G, López JA, Roots I, Stangl K.

J Am Coll Cardiol. 2001 Oct;38(4):1023-7.PMID: 11583876 [PubMed - indexed for MEDLINE]Related articles

High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke.

Elkind MS, Tai W, Coates K, Paik MC, Sacco RL.

Arch Intern Med. 2006 Oct 23;166(19):2073-80.PMID: 17060536 [PubMed - indexed for MEDLINE]Related articlesFree article

Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators.

Kalaria VG, Zareba W, Moss AJ, Pancio G, Marder VJ, Morrissey JH, Weiss HJ, Sparks CE, Greenberg H, Dwyer E, Goldstein R, Watelet LF.

Am J Cardiol. 2000 Jun 15;85(12):1401-8.PMID: 10856383 [PubMed - indexed for MEDLINE]Related articles

The BC genotype of the VNTR polymorphism of platelet glycoprotein Ibalpha is overrepresented in patients with recurrent stroke regardless of aspirin therapy.

Cervera A, Tàssies D, Obach V, Amaro S, Reverter JC, Chamorro A.

Cerebrovasc Dis. 2007;24(2-3):242-6. Epub 2007 Jun 28.PMID: 17630485 [PubMed - indexed for MEDLINE]Related articles

The Kozak sequence polymorphism of platelet glycoprotein Ibalpha and risk of nonfatal myocardial infarction and nonfatal stroke in young women.

Frank MB, Reiner AP, Schwartz SM, Kumar PN, Pearce RM, Arbogast PG, Longstreth WT Jr, Rosendaal FR, Psaty BM, Siscovick DS.

Blood. 2001 Feb 15;97(4):875-9.PMID: 11159511 [PubMed - indexed for MEDLINE]Related articlesFree article

Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation.

Corsetti JP, Zareba W, Moss AJ, Rainwater DL, Sparks CE.

Atherosclerosis. 2006 Jul;187(1):191-7. Epub 2005 Oct 20.PMID: 16242700 [PubMed - indexed for MEDLINE]Related articles

Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death.

May HT, Horne BD, Anderson JL, Wolfert RL, Muhlestein JB, Renlund DG, Clarke JL, Kolek MJ, Bair TL, Pearson RR, Sudhir K, Carlquist JF.

Am Heart J. 2006 Nov;152(5):997-1003.PMID: 17070179 [PubMed - indexed for MEDLINE]Related articles

Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.

Sabatine MS, Morrow DA, O'Donoghue M, Jablonksi KA, Rice MM, Solomon S, Rosenberg Y, Domanski MJ, Hsia J; PEACE Investigators.

Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2463-9. Epub 2007 Aug 31.PMID: 17766330 [PubMed - indexed for MEDLINE]Related articlesFree article

Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndrome.

Corsetti JP, Zareba W, Moss AJ, Sparks CE.

Atherosclerosis. 2004 Dec;177(2):367-73.PMID: 15530912 [PubMed - indexed for MEDLINE]Related articles

The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.

Mohler ER 3rd, Ballantyne CM, Davidson MH, Hanefeld M, Ruilope LM, Johnson JL, Zalewski A; Darapladib Investigators.

J Am Coll Cardiol. 2008 Apr 29;51(17):1632-41.PMID: 18436114 [PubMed - indexed for MEDLINE]Related articles

Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery.

Marcheix B, Vanden Eynden F, Demers P, Bouchard D, Cartier R.

Ann Thorac Surg. 2008 Oct;86(4):1181-8.PMID: 18805157 [PubMed - indexed for MEDLINE]Related articles

Thrombogenic factors and recurrent coronary events.

Moss AJ, Goldstein RE, Marder VJ, Sparks CE, Oakes D, Greenberg H, Weiss HJ, Zareba W, Brown MW, Liang CS, Lichstein E, Little WC, Gillespie JA, Van Voorhees L, Krone RJ, Bodenheimer MM, Hochman J, Dwyer EM Jr, Arora R, Marcus FI, Watelet LF, Case RB.

Circulation. 1999 May 18;99(19):2517-22.PMID: 10330382 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum glucose and triglyceride determine high-risk subgroups in non-diabetic postinfarction patients.

Corsetti JP, Zareba W, Moss AJ, Sparks CE.

Atherosclerosis. 2005 Dec;183(2):293-300. Epub 2005 May 31.PMID: 15925371 [PubMed - indexed for MEDLINE]Related articles